Bacterial And Plasmid Vectors Market Expected To Reach $1.6 Billion By 2030 As Growth Accelerates At 11.9% CAGR
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Bacterial And Plasmid Vectors Market Size Forecast: How Large Could The Market Become By 2030?
The market for bacterial and plasmid vectors has seen substantial growth in the recent past, expanding from $0.92 billion in 2025 to an anticipated $1.02 billion by 2026, achieving a compound annual growth rate (CAGR) of 11.5%. This expansion over the historical period is largely driven by the increase in molecular biology research, the extensive application of E. coli vectors, a rise in biotechnology research funding, the growing demand for protein expression, and the strengthening of academic research efforts.
The bacterial and plasmid vectors market is anticipated to undergo substantial expansion in the coming years, with projections indicating it will reach $1.61 billion by 2030, reflecting a compound annual growth rate (CAGR) of 11.9%. This forecasted growth is largely driven by advances in gene therapy, a surge in biologics production, innovations in synthetic biology, heightened investment in research and development, and an escalating need for high-efficiency vectors. Key developments shaping the forecast period encompass a growing demand for recombinant protein production, an increase in gene cloning applications, the broadening of synthetic biology research, more extensive utilization in academic settings, and ongoing progress in vector engineering.
Download A Free Sample Report For Comprehensive Market Insights:
Bacterial And Plasmid Vectors Market Growth Drivers And Industry Catalysts
The anticipated rise in the prevalence of cancer and infectious diseases is expected to drive demand for the bacterial and plasmid vectors market moving forward. Bacteria serve as vectors for delivering recombinant proteins into target cells to treat cancer and various infectious diseases. This increasing prevalence of cancer and infectious diseases is largely attributed to factors like a growing aging population, lifestyle changes such as poor diet and smoking, environmental pollution, and infectious agents. In cancer and infectious disease research, bacterial and plasmid vectors are employed to deliver therapeutic genes, vaccines, or genetic material capable of stimulating immune responses or correcting genetic defects, thereby assisting in the prevention, treatment, or management of these conditions by addressing underlying causes or strengthening the body’s defenses. For example, in October 2024, the World Health Organization, a Switzerland-based health authority, reported that approximately 10.8 million people worldwide contracted tuberculosis, with 55% being men, 33% women, and 12% children and adolescents, while individuals living with HIV accounted for 6.1% of cases. Consequently, the growing prevalence of cancer and various infectious diseases is fueling the expansion of the bacterial and plasmid vectors market.
Bacterial And Plasmid Vectors Market Segment Performance And Strategic Opportunities
The bacterial and plasmid vectors market covered in this report is segmented –
1) By Host Type: E.Coli Expression Vectors, Other Bacterial Expression Vectors
2) By Application: Genetics, Molecular Biology, Bioinformatics, Other Applications
3) By End Users: Academic And Research Institutes, Biotechnology And Biopharmaceutical Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Industrial And Synthetic Biology Companies, Government And Public Research Laboratories
Subsegments:
1) By E. Coli Expression Vectors: PET Vectors, PUC Vectors, PBR322 Vectors, Expression Systems For Protein Production
2) By Other Bacterial Expression Vectors: Bacillus Subtilis Vectors, Pseudomonas Vectors, Lactococcus Lactis Vectors, Streptomyces Vectors
Bacterial And Plasmid Vectors Market Trends Influencing Long-Term Demand
Major players in the bacterial and plasmid vectors market are prioritizing the creation of cutting-edge tools, such as innovative plasmids, to boost the production of adeno-associated virus (AAV) vectors. These advanced plasmids are specially engineered or modified small circular DNA molecules designed to perform specific, sophisticated roles in biotechnology, gene therapy, or scientific research. For example, in March 2024, Polyplus, a biotechnology firm based in France, unveiled the pPLUS AAV-RC2 plasmid. This product is intended to simplify the manufacturing process and deliver a plug-and-play solution that enhances both the efficiency and dependability of vector production. It boasts distinctive attributes like a ready-to-use format tailored for optimal AAV2 production, notable improvements in viral genome yield when utilized alongside Polyplus transfection reagents, and production under high-quality standards in a GMP-compliant facility.
Bacterial And Plasmid Vectors Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the bacterial and plasmid vectors market are Sigma-Aldrich Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Promega Corporation, GenScript Biotech Corporation, Takara Bio Inc., New England Biolabs, Agilent Technologies, Bio-Rad Laboratories, ATUM, IBA GmbH, Clontech Laboratories Inc., DNA TwoPointO Inc., Creative Biogene, Creative Biomart, OriGene Technologies Inc., Addgene, Lucigen Corporation, Sino Biological Inc., Oxford Genetics Ltd.
Access The Complete Bacterial And Plasmid Vectors Market Report:
Bacterial And Plasmid Vectors Market Regional Analysis And Leading Geography
North America was the largest region in the bacterial & plasmid vectors market in 2025. The Middle East is expected to be the fastest-growing region in the global bacterial & plasmid vectors market share during the forecast period. The regions covered in the bacterial and plasmid vectors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
